Bellco, an Italian company with more than 40 years’ experience, was one of the pioneers in the history of haemodialysis. Bellco operated worldwide, offering systems for the treatment of renal failure, multiple organ failure, sepsis and cardiac decompensation. Its mission was to satisfy the needs of patients and experts through innovation, research and the development of advanced and personalized therapies for nephrology, intensive care and cardiology patients.

Bellco was acquired by Medtronic in February 2016.